14
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T25464 | GRK2 Inhibitor | βARK1 Inhibitor | |
GRK2 Inhibitor is an inhibitor of β-Adrenergic Receptor Kinase 1 (β ARK1). | |||
T79913 | GRK2 Inhibitor 2 | ||
GRK2 Inhibitor 2 (Compound 8h), with an IC50 of 19 nM for GRK2 and 137 nM for Aurora-A, enhances β-AR-mediated cAMP accumulation in GRK2-overexpressing HEK293 cells. It is utilized in congestive heart failure (HF) resear... | |||
T24850 | Takeda103A | CMPD103A,Takeda-103A,Takeda-103-A,CMPD-103A,Takeda 103 A | GRK |
Takeda103A (CMPD103A) is the GRK2-dependent bovine tubulin oxidation effective inhibitor. | |||
T3498 | CCG215022 | GRK , PKA | |
CCG215022 is a G protein-coupled receptor kinases (GRKs) inhibitor with IC50s of 0.15±0.07 μM, 0.38±0.06 μM and 3.9±1 μM for GRK2, 5 and 1, respectively. | |||
T3513 | GSK180736A | GSK180736 | ROCK , GRK , PKA |
GSK180736A is an effective and selective GRK2 inhibitor (IC50: 0.77 μM) and >100-fold selectivity over other GRKs. It is a weak inhibitor of PKA (IC50: 30 μM), but highly effective against ROCK1 (IC50: 100 nM). | |||
T14989 | CMPD101 | ROCK , GRK , PKC | |
CMPD101 is a membrane-permeable small-molecule inhibitor of GRK2/3 (IC50: 18 nM and 5.4 nM). Which can be used for the study of heart failure. CMPD101 exhibits less selectively against GRK1, GRK5, ROCK-2 and PKCα with I... | |||
T1636L | Paroxetine hydrochloride hemihydrate | Paroxetine Hydrochloride,Paxil,Paroxetine HCl,Seroxat | 5-HT Receptor |
Paroxetine hydrochloride hemihydrate (Paxil) is an effective and selective serotonin reuptake inhibitor (SSRI). | |||
T1636 | Paroxetine hydrochloride | Paroxetine HCl,BRL29060 hydrochloride,FG-7051,BRL29060A | 5-HT Receptor , Serotonin Transporter , GRK , AChR , Autophagy |
Paroxetine hydrochloride (Paroxetine HCl) is a serotonin uptake inhibitor that is effective in the treatment of depression. | |||
T27472 | GSK317354A | GSK 317354A,GSK-317354A | |
GSK317354A is a GRK2 inhibitor. | |||
T27479 | GSK466317A | GSK-466317A,GSK 466317A | |
GSK466317A is a GRK2 inhibitor. | |||
T63411 | CCG258747 | ||
CCG258747 is a novel, selective inhibitor of the GRK2 subfamily. | |||
T62986 | CCG-271423 | ||
CCG-271423 is a potent and selective inhibitor of GRK5, acting on both GRK5 (IC50: 0.0021 μM) and GRK2 (IC50: 44 μM). CCG-271423 reduces Ca2+ transients and inhibits cardiomyocyte contractility. | |||
T63340 | CCG-273220 | ||
CCG-273220 is a covalent inhibitor of G protein-coupled receptor (GPCR) kinase 5 (GRK5) (IC50: 220 nM).CCG-273220 covalently binds the GRK5 subfamily-specific residue Cys474 and is more selective for GRK5 than GRK2. | |||
T63203 | GRK5-IN-4 | ||
GRK5-IN-4 is a selective, potent, covalent GRK5 (G protein-coupled receptor kinase 5) inhibitor (IC50: 1.1 μM).GRK5-IN-4 is 90 times more selective for GRK5 than GRK2.GRK5-IN-4 can be used to study heart failure. |